The Role of Public-Private Partnerships in Advancing Dengue Vaccine Solutions: 2023-2030 factviewresearch.com

By Vaccine Type:
• CYD-TDV (Dengvaxia)
• TV003/TV005
• TDV (Takeda)
• V180
• DENVax
By End-User:
• Government Institutions
• Non-Governmental Organizations (NGOs)
• Hospitals
• Clinics
By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Dengue Vaccine Market KEY PLAYERS
• Sanofi Pasteur
• Takeda Pharmaceutical Company Limited
• Butantan Institute
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Johnson & Johnson
• Panacea Biotec Limited
• Inviragen, Inc. (acquired by Takeda)
• VABIOTECH
• Biological E Limited
• GeneOne Life Science Inc.
• Sinovac Biotech Ltd.
• Bharat Biotech
• Instituto Butantan
• Themis Bioscience (acquired by Merck & Co.)
• Pfizer Inc.
• Moderna, Inc.
• CureVac AG
• Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
• PanGen Biotech Inc.
• Vaxart, Inc.
• BioNet-Asia Co., Ltd.
• EuBiologics Co., Ltd.
• Institute of Vaccines and Medical Biologicals (IVAC)